Press Releases April 5, 2026

James River to Hold Its First Quarter Earnings Conference Call on Tuesday, May 5, 2026

James River Group to Report Q1 2026 Earnings and Host Conference Call in Early May

By Derek Hwang JRVR
James River to Hold Its First Quarter Earnings Conference Call on Tuesday, May 5, 2026
JRVR

James River Group Holdings, Inc., a specialty insurance holding company, announced its plan to release first quarter earnings after market close on May 4, 2026, followed by a conference call on May 5, 2026. The company operates in specialty property-casualty insurance segments and maintains strong A- ratings from A.M. Best Company.

Key Points

  • James River will report Q1 2026 earnings on May 4, 2026.
  • The company focuses on specialty property-casualty insurance, including Excess and Surplus Lines and Specialty Admitted Insurance segments.
  • All regulated subsidiaries carry strong A- (Excellent) ratings by A.M. Best Company.

CHAPEL HILL, N.C., April 06, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) will release first quarter earnings after the market closes on Monday, May 4, 2026. It will also host an earnings conference call on Tuesday, May 5, 2026 beginning at 8:00 a.m. (Eastern Time).

The conference call may be accessed by dialing (800) 715-9871, conference ID 1541721, or via the investor website at https://investors.jrvrgroup.com. A replay will also be available in the same location.

About James River Group Holdings, Inc.

James River Group Holdings, Inc. is a holding company that owns and operates a group of specialty insurance companies. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance. Each of the Company’s regulated insurance subsidiaries are rated “A-” (Excellent) by A.M. Best Company. Visit James River Group Holdings, Inc. on the web at https://jrvrgroup.com.

Bob Zimardo
SVP, Investments & Investor Relations
[email protected]


Risks

  • Uncertainty over financial performance reported in the Q1 earnings which could impact investor confidence.
  • Market conditions in the specialty insurance sector, potentially affecting premiums and claims.
  • Regulatory risks affecting insurance subsidiaries in various jurisdictions.

More from Press Releases

Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential Apr 7, 2026 Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit Apr 7, 2026 Director/PDMR Shareholding Apr 7, 2026 Oculis to Participate in Upcoming Investor Conferences Apr 7, 2026 Pharming Group to participate in April investor conferences Apr 7, 2026